329 related articles for article (PubMed ID: 12601442)
1. Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery.
Dagenais F; Mathieu P
Can J Cardiol; 2003 Feb; 19(2):167-9. PubMed ID: 12601442
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
3. [Methylene blue therapy for vasoplegia after cardiac surgery].
Skuza K; Chmielniak S; Dziuk W; Kucewicz E; Pawlak S; Knapik P
Anestezjol Intens Ter; 2009; 41(3):159-62. PubMed ID: 19999604
[TBL] [Abstract][Full Text] [Related]
4. [Methylene blue in the therapy of vasoplegic syndrome after cardiac surgery procedure].
Ríha H; Ríhová L; Pind'ák M; Brezina A; Pirk J
Cas Lek Cesk; 2006; 145(4):322-4. PubMed ID: 16639934
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue administration in severe systemic inflammatory response syndrome (SIRS) after thoracic surgery.
Friedrich M; Bräuer A; Tirilomis T; Lotfi S; Mielck F; Busch T
Ann Thorac Cardiovasc Surg; 2002 Oct; 8(5):306-10. PubMed ID: 12472415
[TBL] [Abstract][Full Text] [Related]
6. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
8. Vasoplegic syndrome--the role of methylene blue.
Shanmugam G
Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
[TBL] [Abstract][Full Text] [Related]
9. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Carley M; Schaff J; Lai T; Poppers J
A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
[TBL] [Abstract][Full Text] [Related]
10. [The significance of neutrophil in inflammatory response after cardiac surgery with cardiopulmonary bypass].
Paśnik J
Wiad Lek; 2007; 60(3-4):171-7. PubMed ID: 17726872
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response.
Kerbaul F; Collart F; Giorgi R; Ibrahim Z; Guillen JC; Gil JM; Saadjian A; Mouly-Bandini A; Habib G; Gouin F; Guieu R
Crit Care Med; 2006 Mar; 34(3):640-5. PubMed ID: 16505647
[TBL] [Abstract][Full Text] [Related]
12. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
Lutjen DL; Arndt KL
AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
[TBL] [Abstract][Full Text] [Related]
13. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study.
Werdan K; Pilz G; Müller-Werdan U; Maas Enriquez M; Schmitt DV; Mohr FW; Neeser G; Schöndube F; Schäfers HJ; Haverich A; Fraunberger P; Andersson J; Kreuzer E; Thijs LG;
Crit Care Med; 2008 Mar; 36(3):716-23. PubMed ID: 18091548
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
Lavigne D
Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):186-9. PubMed ID: 20705641
[TBL] [Abstract][Full Text] [Related]
16. Con: methylene blue should not be used routinely for vasoplegia perioperatively.
Andritsos MJ
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):739-43. PubMed ID: 21684763
[No Abstract] [Full Text] [Related]
17. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
18. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery.
Riha H; Augoustides JG
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):736-8. PubMed ID: 21684764
[No Abstract] [Full Text] [Related]
19. Methylene blue is associated with poor outcomes in vasoplegic shock.
Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
Leyh RG; Kofidis T; Strüber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A
J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
